Robertson Lindsay, Lee Amanda J, Evans Christine J, Boghossian Sheila, Allan Paul L, Ruckley C Vaughan, Fowkes F G R
Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, United Kingdom.
J Vasc Surg Venous Lymphat Disord. 2013 Jan;1(1):59-67. doi: 10.1016/j.jvsv.2012.05.006. Epub 2012 Dec 8.
Epidemiologic research in chronic venous disease has focused on prevalence and associated risk factors. Evidence on the risks and incidence that this condition will develop is limited. The aim of this study was to measure the incidence of new varicose veins and chronic venous insufficiency (CVI) in an adult population and to investigate risk factors associated with the development of these conditions.
The Edinburgh Vein Study is a cohort study of a random sample of the general population. Invitations were sent to 1456 men and women at baseline to participate in a 13-year follow-up examination. Each participant completed a questionnaire on lifestyle and medical history and underwent an examination that included clinical classification of venous disease.
After a mean follow-up of 13.4 (standard deviation, 0.4) years, 880 of 1456 individuals participated (60.4% response). The overall incidence (95% confidence interval [CI]) of C2 varicose veins was 18.2% (15.2%-21.6%), giving an annual incidence rate of 1.4% (1.1%-1.7%), with incidence rates similar in men and women: the 13-year age-adjusted incidence of varicose veins was 15.2% (10.4%-20.0%) in men and 17.4% (13.1%-21.7%) in women (P = .97). The 13-year incidence of varicose veins increased consistently with age from 9.8% in those aged 18 to 34 years to 25.7% in those aged 55 to 64 years (P < .001). The 13-year incidence (95% CI) of CVI was 9.2% (7.0%-11.9%), and the annual incidence rate was 0.7% (0.5%-0.9%). The incidence of CVI was similar in men and women and increased consistently with age (P < .001). Participants with a family history of venous disease were more likely to develop C2 varicose veins (odds ratio, 1.75; 95% CI, 1.12-2.71). Obesity was associated with the development of CVI: the 13-year incidence (95% CI) was 6.1% (3.7%-9.6%) in those who were of normal weight and 23.6% (14.2%-37.0%) in obese participants, with an age-adjusted odds ratio of 3.58 (1.70-7.56).
The Edinburgh Vein Study is one of a few cohort studies to report the incidence of varicose veins and CVI in the general population. The incidence of varicose veins and CVI did not differ significantly by sex and was strongly associated with increasing age. The risk of developing varicose veins was increased in those with a family history, and the risk of CVI was increased in those with higher body mass index.
慢性静脉疾病的流行病学研究主要集中在患病率及相关危险因素。关于这种疾病发生风险和发病率的证据有限。本研究的目的是测量成年人群中新发静脉曲张和慢性静脉功能不全(CVI)的发病率,并调查与这些疾病发生相关的危险因素。
爱丁堡静脉研究是一项对普通人群随机抽样的队列研究。在基线时,向1456名男性和女性发出邀请,参与为期13年的随访检查。每位参与者填写了一份关于生活方式和病史的问卷,并接受了包括静脉疾病临床分类的检查。
平均随访13.4(标准差0.4)年后,1456名个体中有880人参与(应答率60.4%)。C2级静脉曲张的总体发病率(95%置信区间[CI])为18.2%(15.2%-21.6%),年发病率为1.4%(1.1%-1.7%),男性和女性发病率相似:13年年龄调整后的静脉曲张发病率男性为15.2%(10.4%-20.0%),女性为17.4%(13.1%-21.7%)(P = 0.97)。静脉曲张的13年发病率随年龄持续增加,从18至34岁人群中的9.8%增至55至64岁人群中的25.7%(P < 0.001)。CVI的13年发病率(95%CI)为9.2%(7.0%-11.9%),年发病率为0.7%(0.5%-0.9%)。CVI的发病率在男性和女性中相似,且随年龄持续增加(P < 0.001)。有静脉疾病家族史的参与者更易发生C2级静脉曲张(比值比,1.75;95%CI,1.12-2.71)。肥胖与CVI的发生相关:正常体重者的13年发病率(95%CI)为6.1%(3.7%-9.6%),肥胖参与者为23.6%(14.2%-37.0%),年龄调整后的比值比为3.58(1.70-7.56)。
爱丁堡静脉研究是少数报告普通人群中静脉曲张和CVI发病率的队列研究之一。静脉曲张和CVI的发病率在性别上无显著差异,且与年龄增长密切相关。有家族史者发生静脉曲张的风险增加,体重指数较高者发生CVI的风险增加。